← Back
$ELVN All transactions

Enliven Therapeutics, Inc.

▼ SELL 10b5-1 Plan

$ Value

$232K

Shares

10,502

Price

$22

Filed

Jun 18

Insider

Name

Kintz Samuel

Title

PRESIDENT AND CEO

CIK

0001967168

Roles

Director Officer

Transaction Details

Transaction Date

2025-06-17

Code

S

Table

Non-Derivative

Ownership

Indirect

Equity Swap

No

Shares After

954,890

Footnotes

The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 15, 2024. | This transaction was executed in multiple trades at prices ranging from $21.5935 to $22.5793. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. | The shares are held of record by The Kintz & Egan Trust Dated March 30, 2019 for which the reporting person serves as trustee. | This transaction was executed in multiple trades at prices ranging from $22.5945 to $22.9964. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

Filing Info

Accession No.

0001415889-25-017730

Form Type

4

Issuer CIK

0001672619

Kintz Samuel's History

Date Ticker Type Value
2025-11-17 ELVN $273K
2025-10-17 ELVN $267K
2025-09-26 ELVN $74K
2025-09-23 ELVN $56K
2025-09-19 ELVN $20K
2025-09-17 ELVN $95K
2025-08-20 ELVN $30K
2025-08-19 ELVN $12K
2025-08-18 ELVN $208K
2025-07-17 ELVN $90K

Other Insiders at ELVN (90d)

Insider Bought Sold Last
Garland J. Scott 2026-02-12
Kunkel Lori Anne 2026-02-12
Gupta Rishi 2026-02-12
Heyman Richard A. $32K 2026-02-17
Bauer Jake 2026-02-12
Collins Helen Louise
CHIEF MEDICAL OFFICER
$4.0M 2026-04-17
Ballal Rahul D. 2026-02-12
Derynck Mika K 2026-02-12
Hohl Benjamin
CHIEF FINANCIAL OFFICER
$296K 2026-03-06
Lyssikatos Joseph P
CHIEF SCIENTIFIC OFFICER
$145K 2026-02-12
Patel Anish
CHIEF OPERATING OFFICER
2026-02-12